CVS HEALTH CORPORATION REPORTS SECOND QUARTER 2024 RESULTS AND REVISES FULL-YEAR 2024 GUIDANCE

Financial Highlights Second quarter total revenues increased to $91.2 billion, up 2.6% compared to the prior year Second quarter GAAP diluted EPS of $1.41 and Adjusted EPS of $1.83 Generated year-to-date cash flow from operations of $8.0 billion 2024 Full-Year Guidance Revised GAAP…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.